Thrombolysis: Past, present, and future

Postgraduate Medical Journal

Volumn 82, Issue 968, 2006, Pages 372-375

  Gray, D ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ALLERGIC REACTION; ANGIOPLASTY; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY CARE UNIT; COST BENEFIT ANALYSIS; HEART ARRHYTHMIA; HISTORY; HOSPITALIZATION; HUMAN; HYPOTENSION; MEDICAL SOCIETY; META ANALYSIS; MORTALITY; NAUSEA; PRACTICE GUIDELINE; REPERFUSION; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; UNITED KINGDOM; VOMITING;

ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EMERGENCY TREATMENT; FORECASTING; HOSPITALIZATION; HUMANS; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY;

EID: 33745407433     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.033266     Document Type: Review

References (29)

1. Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and observations in fatal acute myocardial infarction: a study of 107 necroscopy patients. Am J Med 1972;52:425-42.
2. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-34.
3. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden death and crescendo angina. Br Heart J 1985;53:363-73.
4. Tillett WS, Garner RL. The fibrinolytic activity of haemolytic streptococci. J Exp Med 1933;58:485-502.
5. Rentrop P, Blanke H, Karch KR, et al. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981;63:307-17.
6. de Bono D. The European Co-operative Study Group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty. J Am Coll Cardiology 1988;12(suppl A):20-3A.
7. The ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity and infarct size at 21 days. N Engl J Med 1986;314:1465-71.
8. Gruppo Italiano Per Lo Studio Della Streptochinasi Nell'Infarto Miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-402.
9. The ISIS-2 Collaborative Study Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
10. The AIMS group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;i:545-9.
11. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
12. Cannon CP, McCabe CH, Diver DJ, et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) 4 trial. J Am Coll Cardiol 1994;24:1602-10.
13. Anon. Randomised, double blind comparison of reteplase double bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995;346:329-36.
14. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial Lancet 1999;354:726-22.
15. Rawles J. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region early anistreplase trial (GREAT). J Am Coll Cardiol 1997;30:1181-6.
16. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
17. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1990;348:771-5.
18. The National Service Framework for Coronary Heart Disease. http://www.doh.gov.uk/nsf/coronary.htm.
19. Myocardial Infarction National Audit Project. http://www.rcplondon.ac.uk/ college/ceeu/ceeu_ami_home.htm.
20. Grines CL, Cox DA, Stone GW, et all, for The Stent Primary Angioplasty in Myocardial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-56.
21. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
22. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomised national multi-centre trial- PRAGUE-2. Eur Heart J 2003;24:94-104.
23. Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction presenting with ST-segment elevation. Eur Heart J 2003;24:28-66.
24. Hammersmith Hospital pioneers new treatment for heart attacks. http://www.hhnt.org/news/paces.htm.
25. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1]: a randomised controlled trial. Lancet 2004;364:1045-53.
26. American Heart Association statistics. http://www.americanheart.org.
27. Herlitz J, Hartford M, Blohm M, et al. Effects of a media campaign on delay time and ambulance use in suspected acute myocardial infarction. Am J Cardiol 1989;64:90-3.
28. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after pre-hospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-6.
29. Boland A, Dundar Y, Bagust A, et al. Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technology Assessment NHS R&D HTA Programme 2003. http://wwwncchta.org.